<DOC>
	<DOCNO>NCT01059175</DOCNO>
	<brief_summary>Cardiac resynchronization therapy ( CRT ) effective treatment heart failure ( HF ) refractory optimal medical management , presence depress left ventricular ( LV ) ejection fraction wide QRS complex . It mainly limit high proportion non-responders . Attempts make , small study , increase number stimulation sit order optimize resynchronization therapy . V3 plan multicenter , randomize trial whose objective evaluate clinical benefit confer addition second endocardial epicardial LV lead non-responders least 6 month standard biventricular stimulation . The V3 trial examine clinical benefit confer addition second LV lead non-responders compare standard CRT .</brief_summary>
	<brief_title>Dual-Site LV Pacing CRT Non Responders : Multicenter Randomized Trial</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Age great 18 year Recipient CRTP CRTD system great 6 standard indication , include LV ejection fraction great 35 percent New York Heart Association ( NYHA ) functional class III IV Optimized biventricular stimulation medical therapy since implantation system Presence sinus rhythm , atrial fibrillation spontaneous induce complete atrioventricular block Greater 93 percent LV stimulation since last device interrogation , LV capture threshold less 5.0 Volts/0.5 millisecond Unchanged worsen clinical status CRT , accord HF composite endpoint describe M. Packer , absence reversible cause Signature write , inform consent participate trial LV lead location great cardiac vein Lifeexpectancy le 1 year due concomitant , noncardiovascular disorder Chronic renal dialysis Concomitant disorder might interfere result V3 trial Blood systolic pressure great 180 millimeter mercury ( mmHg ) diastolic pressure great 95 mmHg despite optimal medical management History stroke , myocardial infarction unstable angina pectoris within last 3 month Presence correctible valvular disease Subject unable attend followup investigative center unable , physical mental reason , comply trial 's procedure , sign inform consent Subject pregnant Subject participate another research project</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Cardiac resynchronization therapy</keyword>
	<keyword>Biventricular stimulation</keyword>
	<keyword>Multisite stimulation</keyword>
	<keyword>Non responder</keyword>
</DOC>